Terbutaline Sulfate NDC 62559-721

NDC codes

FDA NDC Directory

Product NDC (as listed)62559-721Labeler and product segments. Claims need a package NDC.

Product NDC at billing width62559-0721Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
62559-721-01	62559072101	100 TABLET in 1 BOTTLE (62559-721-01)Marketed from Oct 16, 2018

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Terbutaline Sulfate
Generic name (nonproprietary): terbutaline sulfate
Active ingredients: Terbutaline sulfate — 2.5 mg/1
Dosage form: Tablet
Route: Oral
Labeler: ANI Pharmaceuticals, Inc.
Product type: Prescription drug
Marketing category: NDA authorized genericApplication NDA 017849
Marketing start: Oct 16, 2018
Listing expires: Dec 31, 2026
Identifiers: Product ID 62559-721_ee722f8c-05d6-43bc-825d-9496579032c4SPL ID ee722f8c-05d6-43bc-825d-9496579032c4SPL set ID d810a15b-3e10-4f6c-a36e-8ddecbaba9c3RxCUI 857677, 857683UNII 576PU70Y8EUPC 0362559721011, 0362559722018

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N462559072101 followed by a unit qualifier and the quantity

Package 62559-0721-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Nov 15, 2019. This label includes a boxed warning.

Indications (excerpt from the label)

INDICATIONS AND USAGE Terbutaline Sulfate Tablets USP are indicated for the prevention and reversal of bronchospasm in patients 12 years of age and older with asthma and reversible bronchospasm associated with bronchitis and emphysema.

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)